Abstract
Emergence of targetable oncogenic driver alterations has transformed NSCLC treatment models by incorporating tumor genotyping into therapeutic strategies. This study depicts the molecular epidemiology of non-squamous Indian NSCLC and patterns of testing.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
